comprehensive -WSS

comprehensive

author：explore 2025-10-01 15:31:27 - browse：161

Vincent Major (left) and Cristina Gonzalez at the prompt-a-thon organized by NYU Langone. Courtesy Joe Carrotta/ NYU Langone

NEW YORK — A fourth-year medical student, a music therapist, a child psychiatrist, and a physician-researcher stared at their laptops, puzzling over the combination of words that would make a supposedly intelligent system — NYU Langone’s customized version of ChatGPT — think about health care problems in a way that was useful to them.

As part of a “prompt-a-thon” in August at the medical center’s science building, the group had been charged with analyzing a patient record around the theme of equity using NYU’s HIPAA-compliant implementation of the buzzy OpenAI technology that can interpret language and generate text based on queries.

After a morning of mini-lectures, participants broke off into assigned groups and dove into NYU Langone’s newly launched prompting interface. Representatives from Microsoft, which makes the artificial intelligence tool accessible through its cloud services, were on hand to ensure everything ran smoothly as about 70 workshop participants from across the academic medical center put prompts into the system around themes including research, clinical applications, and patient education.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Three trends to watch in biotech in 2024

WSS

A new approach to psychiatric drug development

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Longer MASH drug regimen improved liver, Akero study finds

Why health records don't always know when patients are dead

Biden's 'march

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

knowledge

comprehensive

explore

Cancer drug shortages should be causing more outrage

A new approach to psychiatric drug development

Peter Hotez and the public health issue of online harassment

Immune cells and nerve overgrowth may explain recurring UTI pain

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Families look for replacement for GSK asthma drug Flovent

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: BridgeBio, Akero, and human embryo models

State Dept. review finds Biden bears some blame for Afghanistan failures

Why health records don't always know when patients are dead

knowledge

Carvykti CAR

Albert Bourla of Pfizer: worst biopharma CEO of 2023

First over

Prime Medicine, Myeloid Therapeutics clash over genome

Florida health officials providing scant details on measles cases

Longer MASH drug regimen improved liver, Akero study finds

focus

knowledge

explore

entertainment